FDA's Stem Cell Oversight Faces Pivotal Test In DC Circ.
The D.C. Circuit is poised to shape the future of stem cell therapy as it mulls the extent of the U.S. Food and Drug Administration's power to regulate the potentially revolutionary...To view the full article, register now.
Already a subscriber? Click here to view full article